Physician profile
Beth Diner
NPI 1790765857
$1,053.26
in general payments reported to CMS, 2019-2025
21 companies · $392 in 2025
The $392 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39.69 · 2020: $11.63 · 2022: $111 · 2023: $68.80 · 2024: $430 · 2025: $392.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $864 · Education: $26.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $864.33 |
| Education | $26.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $284.46 | 2022-2025 | Veozah |
| Millicent US INC | $94.44 | 2024-2025 | Intrarosa, Femring |
| Exeltis, USA INC. | $90.43 | 2024-2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $65.60 | 2024-2025 | |
| Sumitomo Pharma America, INC. | $56.91 | 2023-2025 | Myfembree |
| Organon LLC | $54.57 | 2024-2025 | Jada System |
| Convatec INC. | $48.45 | 2024-2025 | |
| Monaghan Medical Corporation | $44.69 | 2024 | Aerobika |
| Abbvie INC. | $41.60 | 2019-2023 | Liletta |
| Integra Lifesciences Corporation | $38.54 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Mayne Pharma Commercial LLC | $35.79 | 2025 | |
| Northgate Technologies, INC. | $33.09 | 2024 | Stimsite |
| Amag Pharmaceuticals, INC. | $25.50 | 2019-2020 | |
| Optumhealth Care Solutions, LLC | $22.98 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Organogenesis INC. | $21.39 | 2024 | Nushield |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| American Regent | $19.21 | 2025 | Injectafer |
| Meditrina | $18.10 | 2024 | |
| Coopersurgical, INC. | $16.42 | 2023 | Advincula Delineator Uterine Manipulator |
| Smith+Nephew, INC. | $15.09 | 2024 | Pico 14 |
| Pfizer INC. | $13.09 | 2019 | |
| Dysis Medical, INC. | $12.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beth Diner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.